MICHAEL N CORRADETTI M.D.
Prescription History 1093977621
Radiology - Radiation Oncology in San Francisco, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MICHAEL N CORRADETTI M.D., an active Radiation Oncology specialist practicing in San Francisco, CA. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 39 documented patient claims. Among these therapy options, the most frequently utilized medication is Lidocaine Hcl Viscous, which accounts for 24 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Lidocaine Hcl ViscousLidocaine Hcl | 24 | $18.77 | ▲ More than typical |
About Lidocaine Hcl Viscous: See also Warning section. Show more ▾ Viscous lidocaine is used to relieve pain and discomfort from a sore throat/mouth. It is also used to numb the lining of the mouth and throat before certain medical/dental procedures (such as dental impressions). This numbing helps prevent the urge to close the throat (gag reflex), which might make the procedure more difficult. Lidocaine belongs to a class of drugs known as local anesthetics. A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. In 2024, this provider wrote 24 Medicare prescriptions for Lidocaine Hcl Viscous, about 1.3 times the volume of the typical California prescriber of this medication (18.9). Medicare paid an average of $18.77 per fill, versus $17.16 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24.2 30-Day Fills standardized to 30-day supplies 190 Days of Medication total across all patients in 2024 | |||
| Sucralfate | 15 | $139.86 | ▼ Less than typical |
About Sucralfate: This medication is used to treat and prevent ulcers in the intestines. Show more ▾ Sucralfate forms a coating over ulcers, protecting the area from further injury. This helps ulcers heal more quickly. A basic aluminum complex of sulfated sucrose. In 2024, this provider wrote 15 Medicare prescriptions for Sucralfate, about half the volume of the typical California prescriber of this medication (26.8). Medicare paid an average of $139.86 per fill, versus $58.68 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 267 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MICHAEL N CORRADETTI M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Radiation Oncology prescribing approach at this San Francisco, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
